-
1
-
-
84909629461
-
Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: Past, present, and future
-
Kima HY, Park JW. Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future. Liver Cancer 2014;3:9-17.
-
(2014)
Liver Cancer
, vol.3
, pp. 9-17
-
-
Kima, H.Y.1
Park, J.W.2
-
2
-
-
33644857025
-
Gene regulation by microRNAs
-
Carthew RW. Gene regulation by microRNAs. Curr Opin Genet Dev 2006;16:203-8.
-
(2006)
Curr Opin Genet Dev
, vol.16
, pp. 203-208
-
-
Carthew, R.W.1
-
3
-
-
11844278458
-
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are micro-RNA targets
-
Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are micro-RNA targets. Cell 2005;120:15-20.
-
(2005)
Cell
, vol.120
, pp. 15-20
-
-
Lewis, B.P.1
Burge, C.B.2
Bartel, D.P.3
-
4
-
-
49949117302
-
Widespread changes in protein synthesis induced by microRNAs
-
Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008;455:58-63.
-
(2008)
Nature
, vol.455
, pp. 58-63
-
-
Selbach, M.1
Schwanhausser, B.2
Thierfelder, N.3
Fang, Z.4
Khanin, R.5
Rajewsky, N.6
-
5
-
-
82955172675
-
MicroRNAs in human diseases: From cancer to cardiovascular disease
-
Ha TY. MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 2011;11:135-54.
-
(2011)
Immune Netw
, vol.11
, pp. 135-154
-
-
Ha, T.Y.1
-
6
-
-
33645321647
-
MicroRNAs in cell proliferation, cell death, and tumorigenesis
-
Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006;94:776-80.
-
(2006)
Br J Cancer
, vol.94
, pp. 776-780
-
-
Hwang, H.W.1
Mendell, J.T.2
-
7
-
-
84877258007
-
Treatment of HCV infection by targeting microRNA
-
Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013;368:1685-94.
-
(2013)
N Engl J Med
, vol.368
, pp. 1685-1694
-
-
Janssen, H.L.1
Reesink, H.W.2
Lawitz, E.J.3
Zeuzem, S.4
Rodriguez-Torres, M.5
Patel, K.6
-
8
-
-
34250851115
-
MicroRNA component of the p53 tumor suppressor network
-
He L, He X, Lim LP, Stanchina ED, Xuan Z, Liang Y, et al. MicroRNA component of the p53 tumor suppressor network. Nature 2003;447: 1130-4.
-
(2003)
Nature
, vol.447
, pp. 1130-1134
-
-
He, L.1
He, X.2
Lim, L.P.3
Stanchina, E.D.4
Xuan, Z.5
Liang, Y.6
-
9
-
-
34249812122
-
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
-
Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007;26:5017-22.
-
(2007)
Oncogene
, vol.26
, pp. 5017-5022
-
-
Welch, C.1
Chen, Y.2
Stallings, R.L.3
-
10
-
-
34547458550
-
P53-mediated activation of miRNA-34 candicate tumor-suppressor genes
-
Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE. P53-mediated activation of miRNA-34 candicate tumor-suppressor genes. Curr Biol 2007;17:1298-307.
-
(2007)
Curr Biol
, vol.17
, pp. 1298-1307
-
-
Bommer, G.T.1
Gerin, I.2
Feng, Y.3
Kaczorowski, A.J.4
Kuick, R.5
Love, R.E.6
-
12
-
-
34250868124
-
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: MiR-34a is a p53 target that induces apoptosis and G1-arrest
-
Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007;6:1586-93.
-
(2007)
Cell Cycle
, vol.6
, pp. 1586-1593
-
-
Tarasov, V.1
Jung, P.2
Verdoodt, B.3
Lodygin, D.4
Epanchintsev, A.5
Menssen, A.6
-
13
-
-
34848868157
-
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
-
Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad SciUS A 2007;104:15472-7.
-
(2007)
Proc Natl Acad SciUS A
, vol.104
, pp. 15472-15477
-
-
Tazawa, H.1
Tsuchiya, N.2
Izumiya, M.3
Nakagama, H.4
-
14
-
-
49249121155
-
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer
-
Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008;68:4123-32.
-
(2008)
Cancer Res
, vol.68
, pp. 4123-4132
-
-
Toyota, M.1
Suzuki, H.2
Sasaki, Y.3
Maruyama, R.4
Imai, K.5
Shinomura, Y.6
-
15
-
-
67651098994
-
MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation
-
Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, Lee B. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009;114:404-14.
-
(2009)
Blood
, vol.114
, pp. 404-414
-
-
Hashimi, S.T.1
Fulcher, J.A.2
Chang, M.H.3
Gov, L.4
Wang, S.5
Lee, B.6
-
16
-
-
34249817549
-
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
-
Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26: 745-52.
-
(2007)
Mol Cell
, vol.26
, pp. 745-752
-
-
Chang, T.C.1
Wentzel, E.A.2
Kent, O.A.3
Ramachandran, K.4
Mullendore, M.5
Lee, K.H.6
-
17
-
-
58549114916
-
MiR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
-
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 2009;275:44-53.
-
(2009)
Cancer Lett
, vol.275
, pp. 44-53
-
-
Li, N.1
Fu, H.2
Tie, Y.3
Hu, Z.4
Kong, W.5
Wu, Y.6
-
18
-
-
54749089002
-
Small-molecule inhibitors of microrna miR-21 function
-
Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A. Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 2008;47:7482-4.
-
(2008)
Angew Chem Int Ed Engl
, vol.47
, pp. 7482-7484
-
-
Gumireddy, K.1
Young, D.D.2
Xiong, X.3
Hogenesch, J.B.4
Huang, Q.5
Deiters, A.6
-
19
-
-
77953312157
-
Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma
-
Young DD, Connelly CM, Grohmann C, Deiters A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc 2010;132:7976-81.
-
(2010)
J Am Chem Soc
, vol.132
, pp. 7976-7981
-
-
Young, D.D.1
Connelly, C.M.2
Grohmann, C.3
Deiters, A.4
-
20
-
-
0019966544
-
Growth of human hepatoma cell lines with differentiated functions in chemically defined medium
-
Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982;42:3858-63.
-
(1982)
Cancer Res
, vol.42
, pp. 3858-3863
-
-
Nakabayashi, H.1
Taketa, K.2
Miyano, K.3
Yamane, T.4
Sato, J.5
-
21
-
-
0033960043
-
A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice
-
Brown JJ, Parashar B, Moshage H, Tanaka KE, Engelhardt D, Rabbani E, et al. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice. Hepatology 2000;31:173-81.
-
(2000)
Hepatology
, vol.31
, pp. 173-181
-
-
Brown, J.J.1
Parashar, B.2
Moshage, H.3
Tanaka, K.E.4
Engelhardt, D.5
Rabbani, E.6
-
22
-
-
0018982124
-
Establishment of three human liver carcinoma cell lines and someof their biological characteristics in vitro
-
Chen R, Zhu D, Ye X, Shen D, Lu R. Establishment of three human liver carcinoma cell lines and someof their biological characteristics in vitro. Sci Sin 1980;23:236-47.
-
(1980)
Sci Sin
, vol.23
, pp. 236-247
-
-
Chen, R.1
Zhu, D.2
Ye, X.3
Shen, D.4
Lu, R.5
-
23
-
-
34547487035
-
Lentivirusmediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin
-
Chen Y, Lin MC, Yao H, Wang H, Zhang AQ, Yu J, et al. Lentivirusmediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007;46:200-8.
-
(2007)
Hepatology
, vol.46
, pp. 200-208
-
-
Chen, Y.1
Lin, M.C.2
Yao, H.3
Wang, H.4
Zhang, A.Q.5
Yu, J.6
-
24
-
-
84896699958
-
Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinoma
-
Xiao Z, Chow SC, Li CH, Tang CS, Tsui SK, Lin Z, et al. Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinoma. Eur J Pharmacol 2014;728:141-50.
-
(2014)
Eur J Pharmacol
, vol.728
, pp. 141-150
-
-
Xiao, Z.1
Chow, S.C.2
Li, C.H.3
Tang, C.S.4
Tsui, S.K.5
Lin, Z.6
-
25
-
-
84876482603
-
Enhancer of zeste homolog 2 silences miR-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin
-
Li CH, To KF, Tong JH, Xiao Z, Xia T, Lai PB, et al. Enhancer of zeste homolog 2 silences miR-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Gastroenterology 2013;144:1086-97.
-
(2013)
Gastroenterology
, vol.144
, pp. 1086-1097
-
-
Li, C.H.1
To, K.F.2
Tong, J.H.3
Xiao, Z.4
Xia, T.5
Lai, P.B.6
-
26
-
-
70349393847
-
Differential expression of microRNAs in mouse liver under aberrant energy metabolic status
-
Li S, Chen X, Zhang H, Liang X, Xiang Y, Yu C, et al. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res 2009;50:1756-65.
-
(2009)
J Lipid Res
, vol.50
, pp. 1756-1765
-
-
Li, S.1
Chen, X.2
Zhang, H.3
Liang, X.4
Xiang, Y.5
Yu, C.6
-
27
-
-
84874700585
-
MicroRNA-34a regulates cardiac ageing and function
-
Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, et al. MicroRNA-34a regulates cardiac ageing and function. Nature 2013;495:107-10.
-
(2013)
Nature
, vol.495
, pp. 107-110
-
-
Boon, R.A.1
Iekushi, K.2
Lechner, S.3
Seeger, T.4
Fischer, A.5
Heydt, S.6
-
28
-
-
84867903854
-
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function
-
Bernardo BC, Gao XM, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A 2012;109:17615-20.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 17615-17620
-
-
Bernardo, B.C.1
Gao, X.M.2
Winbanks, C.E.3
Boey, E.J.4
Tham, Y.K.5
Kiriazis, H.6
-
29
-
-
84896339739
-
Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy
-
Bernardo BC, Gao XM, Tham YK, Kiriazis H, Winbanks CE, Ooi JY, et al. Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy. PLoS ONE 2014;9:e90337.
-
(2014)
PLoS ONE
, vol.9
, pp. e90337
-
-
Bernardo, B.C.1
Gao, X.M.2
Tham, Y.K.3
Kiriazis, H.4
Winbanks, C.E.5
Ooi, J.Y.6
-
30
-
-
84905654192
-
Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type i glycogen storage disease: A potential utility as biomarkers
-
Chiu LY, Kishnani PS, Chuang TP, Tang CY, Liu CY, Bali D, et al. Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. J Gastroenterol 2013;49:1274-84.
-
(2013)
J Gastroenterol
, vol.49
, pp. 1274-1284
-
-
Chiu, L.Y.1
Kishnani, P.S.2
Chuang, T.P.3
Tang, C.Y.4
Liu, C.Y.5
Bali, D.6
-
31
-
-
79551543164
-
Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma
-
Mizuguchi Y, Mishima T, Yokomuro S, Arima Y, Kawahigashi Y, Shigehara K, et al. Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS ONE 2011;6:e15304.
-
(2011)
PLoS ONE
, vol.6
, pp. e15304
-
-
Mizuguchi, Y.1
Mishima, T.2
Yokomuro, S.3
Arima, Y.4
Kawahigashi, Y.5
Shigehara, K.6
-
32
-
-
84869219338
-
MiR-34-A microRNA replacement therapy is headed to the clinic
-
Bader AG. miR-34-a microRNA replacement therapy is headed to the clinic. Front Genet 2012;3:120.
-
(2012)
Front Genet
, vol.3
, pp. 120
-
-
Bader, A.G.1
-
34
-
-
84878546600
-
Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
-
Lou W, Chen Q, Ma L, Liu J, Yang Z, Shen J, et al. Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. J Mol Med 2013;91:715-25.
-
(2013)
J Mol Med
, vol.91
, pp. 715-725
-
-
Lou, W.1
Chen, Q.2
Ma, L.3
Liu, J.4
Yang, Z.5
Shen, J.6
-
35
-
-
84866018690
-
TGF-betamiR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma
-
Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S, et al. TGF-betamiR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 2012;22:291-303.
-
(2012)
Cancer Cell
, vol.22
, pp. 291-303
-
-
Yang, P.1
Li, Q.J.2
Feng, Y.3
Zhang, Y.4
Markowitz, G.J.5
Ning, S.6
-
36
-
-
7744236941
-
Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma
-
Lee J, Park JO, Kim WS, Park SH, Park KW, Choi MS, et al. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma. Cancer Chemother Pharmacol 2004;54:385-90.
-
(2004)
Cancer Chemother Pharmacol
, vol.54
, pp. 385-390
-
-
Lee, J.1
Park, J.O.2
Kim, W.S.3
Park, S.H.4
Park, K.W.5
Choi, M.S.6
-
37
-
-
55749088393
-
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
-
Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther 2008;7:3129-40.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 3129-3140
-
-
Wilhelm, S.M.1
Adnane, L.2
Newell, P.3
Villanueva, A.4
Llovet, J.M.5
Lynch, M.6
-
38
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-90.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
-
39
-
-
52949138886
-
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib
-
Lacouture ME, Reilly LM, Gerami P, Guitart J. Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. Ann Oncol 2008;19:1955-61.
-
(2008)
Ann Oncol
, vol.19
, pp. 1955-1961
-
-
Lacouture, M.E.1
Reilly, L.M.2
Gerami, P.3
Guitart, J.4
-
40
-
-
80052851473
-
Comparing the efficacy of sunitinib with sorafenib in xenograft models of human hepatocellular carcinoma: Mechanistic explanation
-
Huynh H, Choo SP, Toh HC, Tai WM, Chung AY, Chow PK, et al. Comparing the efficacy of sunitinib with sorafenib in xenograft models of human hepatocellular carcinoma: mechanistic explanation. Curr Cancer Drug Targets 2011;11:944-53.
-
(2011)
Curr Cancer Drug Targets
, vol.11
, pp. 944-953
-
-
Huynh, H.1
Choo, S.P.2
Toh, H.C.3
Tai, W.M.4
Chung, A.Y.5
Chow, P.K.6
-
42
-
-
84894060596
-
MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment
-
Yang F, Li QJ, Gong ZB, Zhou L, You N, Wang S, et al. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment. Technol Cancer Res Treat 2014;13:77-86.
-
(2014)
Technol Cancer Res Treat
, vol.13
, pp. 77-86
-
-
Yang, F.1
Li, Q.J.2
Gong, Z.B.3
Zhou, L.4
You, N.5
Wang, S.6
-
43
-
-
0030941458
-
P53: The cellular gatekeeper for growth and division
-
Levine AJ. p53: the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
-
(1997)
Cell
, vol.88
, pp. 323-331
-
-
Levine, A.J.1
-
45
-
-
48749103325
-
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
-
Boeckler FM, Joerger AC, Jaggi G, Rutherford TJ, Veprintsev DB, Fersht AR. Targeted rescue of a destabilized mutant of p53 by an in silico screened drug. Proc Natl Acad Sci U S A 2008;105:10360-5.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 10360-10365
-
-
Boeckler, F.M.1
Joerger, A.C.2
Jaggi, G.3
Rutherford, T.J.4
Veprintsev, D.B.5
Fersht, A.R.6
-
46
-
-
0347130901
-
Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide: Implications for "mutant conformation"
-
Friedler A, DeDecker BS, Freund SM, Blair C, Rudiger S, Fersht AR. Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide: implications for "mutant conformation". J Mol Biol 2004;336:187-96.
-
(2004)
J Mol Biol
, vol.336
, pp. 187-196
-
-
Friedler, A.1
Dedecker, B.S.2
Freund, S.M.3
Blair, C.4
Rudiger, S.5
Fersht, A.R.6
-
47
-
-
0025828517
-
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
-
Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-31.
-
(1991)
Nature
, vol.350
, pp. 429-431
-
-
Bressac, B.1
Kew, M.2
Wands, J.3
Ozturk, M.4
-
48
-
-
0022547592
-
Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma
-
Dejean A, Bougueleret L, Grzeschik KH, Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 1986;322: 70-2.
-
(1986)
Nature
, vol.322
, pp. 70-72
-
-
Dejean, A.1
Bougueleret, L.2
Grzeschik, K.H.3
Tiollais, P.4
-
49
-
-
0025022001
-
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
-
Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990;343:555-7.
-
(1990)
Nature
, vol.343
, pp. 555-557
-
-
Wang, J.1
Chenivesse, X.2
Henglein, B.3
Brechot, C.4
-
50
-
-
84880935149
-
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
-
Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 2013;102:74-83.
-
(2013)
Genomics
, vol.102
, pp. 74-83
-
-
Tornesello, M.L.1
Buonaguro, L.2
Tatangelo, F.3
Botti, G.4
Izzo, F.5
Buonaguro, F.M.6
|